Industry Research Reports

Home > Reports > Medical Care > Global Adeno-Associated Virus (AAV) Packaging Service Market Outlook, In‑Depth Analysis & Forecast to 2032

Global Adeno-Associated Virus (AAV) Packaging Service Market Outlook, In‑Depth Analysis & Forecast to 2032

Industry: Medical Care

Published Date: 2026-07-18

Pages: 161 Pages

Report ld: 6276590

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Adeno-Associated Virus (AAV) Packaging Service Market Size(US$)

CAGR 2026-2032

11.1%

Market Size,2032

USD 2,627

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 1,397 million

Market Forecast in 2032(Value)

US$ 2,627 million

CAGR

11.1%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Adeno-Associated Virus (AAV) Packaging Service market is projected to grow from US$ 1249 million in 2025 to US$ 2627 million by 2032, at a CAGR of 11.1% (2026-2032), driven by critical product segments and diverse end‑use applications.

Adeno-associated virus (AAV) packaging services refer to customized development and manufacturing activities in which a customer-provided or jointly designed ITR-containing construct is packaged into a recombinant AAV vector carrying a gene of interest, gene-silencing sequence, gene-editing component or reporter gene. The service workflow generally includes vector design and construction, plasmid preparation, cell culture and transfection, vector harvest, purification, concentration, aliquoting and quality testing, covering research-grade, preclinical-grade and GMP-grade projects. Key upstream inputs include transfer plasmids, Rep/Cap plasmids, helper plasmids, HEK293 or Sf9 cells, culture media, transfection reagents, nucleases, chromatography resins, filtration consumables and analytical reagents. Major downstream customers include universities, research institutes, hospital research platforms, gene therapy developers, biotechnology companies, pharmaceutical companies and CROs, with applications spanning basic research, animal studies, preclinical evaluation, IND submissions, clinical development and commercial manufacturing. The industry's overall gross margin is generally estimated at approximately 32%-48%.

The global market consists of research-grade packaging providers, specialized AAV CROs, integrated cell and gene therapy CDMOs and large biopharmaceutical service groups operating dedicated AAV platforms. Research-grade projects are numerous, relatively short and fragmented, with competition centered on serotype coverage, titer, purity, turnaround time and price. Preclinical and GMP programs are less frequent but require considerably greater investment in process scale-up, analytical methods, batch consistency, quality systems and regulatory documentation. Providers capable of maintaining process continuity from vector design and small-scale packaging through GMP and commercial manufacturing generally develop stronger customer retention, particularly after a program enters clinical development.

Demand is supported by gene-function research, rare-disease and neurological gene therapy, engineered-capsid screening, gene-editing delivery and greater outsourcing by biotechnology companies. Different AAV capsids enable gene delivery to the eye, liver, central nervous system, muscle and other tissues, while dual- and multi-vector systems extend the technology to larger or more complex payloads. The FDA's 2026 approval of the first dual-AAV gene therapy for inherited hearing loss demonstrates the continued expansion of AAV into new vector configurations and therapeutic areas, supporting demand for dual-vector development, analytics and scalable manufacturing.

Adherent HEK293 triple-plasmid transfection remains widely used for research and smaller programs, while suspension HEK293 systems have become the principal route for clinical and commercial scale-up. Baculovirus-Sf9 systems are used in selected large-scale processes. Stable producer-cell lines, dual-plasmid systems and plasmid-reduced technologies are being developed to lower raw-material costs and improve consistency. Downstream competition is moving beyond vector-genome titer toward full-capsid enrichment, genome-integrity control and tighter reduction of host-cell proteins, residual DNA, residual plasmids and replication-competent AAV.

The principal constraints include gene therapy financing and pipeline reprioritization, high clinical attrition, underutilized GMP facilities, elevated manufacturing costs and the immunological and safety limitations of AAV. Serious liver-related safety events led the FDA to restrict the use of a major AAV gene therapy in 2025, increasing the focus on dose selection, impurity control, clinical monitoring and long-term follow-up. At the same time, the FDA introduced a more flexible approach to certain cell and gene therapy CMC requirements in 2026, which may help selected rare-disease programs progress more efficiently but does not reduce expectations for identity, potency, purity and manufacturing consistency.

Report Includes:

This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Adeno-Associated Virus (AAV) Packaging Service market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.

Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

Thermo Fisher Scientific
Lonza
Charles River Laboratories
Catalent
AGC Biologics
SK pharmteco
OXB
Forge Biologics
Viralgen
Andelyn Biosciences
Revvity
Virovek
Fortis Life Sciences
SignaGen Laboratories
Applied Biological Materials
Takara Bio
VectorBuilder
GenScript ProBio
PackGene Biotech
OBiO Technology
Porton Advanced
HanBio

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Research Grade
Preclinical Grade
GMP Grade

Segment by Application

Academic and Research Institutions
Biotechnology Companies
Other

Segment by Category

Packaging Only
Vector Construction and Packaging
End-to-End Development and Manufacturing

Segment by Division

Adherent HEK293
Suspension HEK293
Baculovirus-Sf9
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the Adeno-Associated Virus (AAV) Packaging Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential

Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts

Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves

Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application

Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers

Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers

Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas

Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges

Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles

Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments

Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels

Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies

Chapter 14: Actionable conclusions and strategic recommendations.

Why This Report?

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Introduction to Adeno-Associated Virus (AAV) Packaging Service: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Size by Type, 2021 vs 2025 vs 2032

1.2.2 Research Grade

1.2.3 Preclinical Grade

1.2.4 GMP Grade

1.3 Market Segmentation by Service Scope

1.3.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Size by Service Scope, 2021 vs 2025 vs 2032

1.3.2 Packaging Only

1.3.3 Vector Construction and Packaging

1.3.4 End-to-End Development and Manufacturing

1.4 Market Segmentation by Production Platform

1.4.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Size by Production Platform, 2021 vs 2025 vs 2032

1.4.2 Adherent HEK293

1.4.3 Suspension HEK293

1.4.4 Baculovirus-Sf9

1.4.5 Other

1.5 Market Segmentation by Application

1.5.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Size by Application, 2021 vs 2025 vs 2032

1.5.2 Academic and Research Institutions

1.5.3 Biotechnology Companies

1.5.4 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Executive Summary

2.1 Global Adeno-Associated Virus (AAV) Packaging Service Revenue Estimates and Forecasts (2021-2032)

2.2 Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Region

2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032

2.2.2 Historical and Forecasted Revenue by Region (2021-2032)

2.2.3 Global Revenue-Based Market Share by Region (2021-2032)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competitive Landscape

3.1 Global Adeno-Associated Virus (AAV) Packaging Service Players’ Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2021-2026)

3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Players (2021 vs 2025)

3.2 Global Adeno-Associated Virus (AAV) Packaging Service Companies Headquarters and Service Footprint

3.3 Key Player Market Share by Product Type

3.3.1 Research Grade: Market Share by Key Players

3.3.2 Preclinical Grade: Market Share by Key Players

3.3.3 GMP Grade: Market Share by Key Players

3.4 Global Adeno-Associated Virus (AAV) Packaging Service Market Concentration and Dynamics

3.4.1 Global Market Concentration

3.4.2 Market Entry and Exit Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Product Segmentation

4.1 Global Adeno-Associated Virus (AAV) Packaging Service Market by Type

4.1.1 Global Revenue by Type (2021-2032)

4.1.2 Global Revenue-Based Market Share by Type (2021-2032)

4.2 Global Adeno-Associated Virus (AAV) Packaging Service Market by Service Scope

4.2.1 Global Revenue by Service Scope (2021-2032)

4.2.2 Global Revenue-Based Market Share by Service Scope (2021-2032)

4.3 Global Adeno-Associated Virus (AAV) Packaging Service Market by Production Platform

4.3.1 Global Revenue by Production Platform (2021-2032)

4.3.2 Global Revenue-Based Market Share by Production Platform (2021-2032)

4.4 Key Product Attributes and Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Downstream Applications and Customers

5.1 Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)

5.1.2 Revenue-Based Market Share by Application (2021-2032)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2021-2032)

6.2 North America Key Players’ Revenue in 2025

6.3 North America Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2021-2032)

6.4 North America Growth Accelerators and Market Barriers

6.5 North America Adeno-Associated Virus (AAV) Packaging Service Market Size by Country

6.5.1 North America Revenue Trends by Country

6.5.2 US

6.5.3 Canada

6.5.4 Mexico

7 Europe

7.1 Europe Market Size (2021-2032)

7.2 Europe Key Players’ Revenue in 2025

7.3 Europe Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2021-2032)

7.4 Europe Growth Accelerators and Market Barriers

7.5 Europe Adeno-Associated Virus (AAV) Packaging Service Market Size by Country

7.5.1 Europe Revenue Trends by Country

7.5.2 Germany

7.5.3 France

7.5.4 U.K.

7.5.5 Italy

7.5.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2021-2032)

8.2 Asia-Pacific Key Players’ Revenue in 2025

8.3 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2021-2032)

8.4 Asia-Pacific Growth Accelerators and Market Barriers

8.5 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size by Region

8.5.1 Asia-Pacific Revenue Trends by Region

8.6 China

8.7 Japan

8.8 South Korea

8.9 Australia

8.10 India

8.11 Southeast Asia

8.11.1 Indonesia

8.11.2 Vietnam

8.11.3 Malaysia

8.11.4 Philippines

8.11.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2021-2032)

9.2 Central and South America Key Players’ Revenue in 2025

9.3 Central and South America Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2021-2032)

9.4 Central and South America Investment Opportunities and Key Challenges

9.5 Central and South America Adeno-Associated Virus (AAV) Packaging Service Market Size by Country

9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)

9.5.2 Brazil

9.5.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2021-2032)

10.2 Middle East and Africa Key Players’ Revenue in 2025

10.3 Middle East and Africa Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2021-2032)

10.4 Middle East and Africa Investment Opportunities and Key Challenges

10.5 Middle East and Africa Adeno-Associated Virus (AAV) Packaging Service Market Size by Country

10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)

10.5.2 GCC Countries

10.5.3 Israel

10.5.4 Egypt

10.5.5 South Africa

11 Corporate Profile

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Corporation Information

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.1.4 Thermo Fisher Scientific Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.1.5 Thermo Fisher Scientific Adeno-Associated Virus (AAV) Packaging Service Revenue by Product in 2025

11.1.6 Thermo Fisher Scientific Adeno-Associated Virus (AAV) Packaging Service Revenue by Application in 2025

11.1.7 Thermo Fisher Scientific Adeno-Associated Virus (AAV) Packaging Service Revenue by Geographic Area in 2025

11.1.8 Thermo Fisher Scientific Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis

11.1.9 Thermo Fisher Scientific Recent Developments

11.2 Lonza

11.2.1 Lonza Corporation Information

11.2.2 Lonza Business Overview

11.2.3 Lonza Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.2.4 Lonza Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.2.5 Lonza Adeno-Associated Virus (AAV) Packaging Service Revenue by Product in 2025

11.2.6 Lonza Adeno-Associated Virus (AAV) Packaging Service Revenue by Application in 2025

11.2.7 Lonza Adeno-Associated Virus (AAV) Packaging Service Revenue by Geographic Area in 2025

11.2.8 Lonza Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis

11.2.9 Lonza Recent Developments

11.3 Charles River Laboratories

11.3.1 Charles River Laboratories Corporation Information

11.3.2 Charles River Laboratories Business Overview

11.3.3 Charles River Laboratories Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.3.4 Charles River Laboratories Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.3.5 Charles River Laboratories Adeno-Associated Virus (AAV) Packaging Service Revenue by Product in 2025

11.3.6 Charles River Laboratories Adeno-Associated Virus (AAV) Packaging Service Revenue by Application in 2025

11.3.7 Charles River Laboratories Adeno-Associated Virus (AAV) Packaging Service Revenue by Geographic Area in 2025

11.3.8 Charles River Laboratories Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis

11.3.9 Charles River Laboratories Recent Developments

11.4 Catalent

11.4.1 Catalent Corporation Information

11.4.2 Catalent Business Overview

11.4.3 Catalent Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.4.4 Catalent Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.4.5 Catalent Adeno-Associated Virus (AAV) Packaging Service Revenue by Product in 2025

11.4.6 Catalent Adeno-Associated Virus (AAV) Packaging Service Revenue by Application in 2025

11.4.7 Catalent Adeno-Associated Virus (AAV) Packaging Service Revenue by Geographic Area in 2025

11.4.8 Catalent Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis

11.4.9 Catalent Recent Developments

11.5 AGC Biologics

11.5.1 AGC Biologics Corporation Information

11.5.2 AGC Biologics Business Overview

11.5.3 AGC Biologics Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.5.4 AGC Biologics Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.5.5 AGC Biologics Adeno-Associated Virus (AAV) Packaging Service Revenue by Product in 2025

11.5.6 AGC Biologics Adeno-Associated Virus (AAV) Packaging Service Revenue by Application in 2025

11.5.7 AGC Biologics Adeno-Associated Virus (AAV) Packaging Service Revenue by Geographic Area in 2025

11.5.8 AGC Biologics Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis

11.5.9 AGC Biologics Recent Developments

11.6 SK pharmteco

11.6.1 SK pharmteco Corporation Information

11.6.2 SK pharmteco Business Overview

11.6.3 SK pharmteco Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.6.4 SK pharmteco Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.6.5 SK pharmteco Recent Developments

11.7 OXB

11.7.1 OXB Corporation Information

11.7.2 OXB Business Overview

11.7.3 OXB Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.7.4 OXB Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.7.5 OXB Recent Developments

11.8 Forge Biologics

11.8.1 Forge Biologics Corporation Information

11.8.2 Forge Biologics Business Overview

11.8.3 Forge Biologics Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.8.4 Forge Biologics Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.8.5 Forge Biologics Recent Developments

11.9 Viralgen

11.9.1 Viralgen Corporation Information

11.9.2 Viralgen Business Overview

11.9.3 Viralgen Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.9.4 Viralgen Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.9.5 Viralgen Recent Developments

11.10 Andelyn Biosciences

11.10.1 Andelyn Biosciences Corporation Information

11.10.2 Andelyn Biosciences Business Overview

11.10.3 Andelyn Biosciences Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.10.4 Andelyn Biosciences Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.10.5 Company Ten Recent Developments

11.11 Revvity

11.11.1 Revvity Corporation Information

11.11.2 Revvity Business Overview

11.11.3 Revvity Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.11.4 Revvity Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.11.5 Revvity Recent Developments

11.12 Virovek

11.12.1 Virovek Corporation Information

11.12.2 Virovek Business Overview

11.12.3 Virovek Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.12.4 Virovek Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.12.5 Virovek Recent Developments

11.13 Fortis Life Sciences

11.13.1 Fortis Life Sciences Corporation Information

11.13.2 Fortis Life Sciences Business Overview

11.13.3 Fortis Life Sciences Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.13.4 Fortis Life Sciences Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.13.5 Fortis Life Sciences Recent Developments

11.14 SignaGen Laboratories

11.14.1 SignaGen Laboratories Corporation Information

11.14.2 SignaGen Laboratories Business Overview

11.14.3 SignaGen Laboratories Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.14.4 SignaGen Laboratories Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.14.5 SignaGen Laboratories Recent Developments

11.15 Applied Biological Materials

11.15.1 Applied Biological Materials Corporation Information

11.15.2 Applied Biological Materials Business Overview

11.15.3 Applied Biological Materials Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.15.4 Applied Biological Materials Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.15.5 Applied Biological Materials Recent Developments

11.16 Takara Bio

11.16.1 Takara Bio Corporation Information

11.16.2 Takara Bio Business Overview

11.16.3 Takara Bio Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.16.4 Takara Bio Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.16.5 Takara Bio Recent Developments

11.17 VectorBuilder

11.17.1 VectorBuilder Corporation Information

11.17.2 VectorBuilder Business Overview

11.17.3 VectorBuilder Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.17.4 VectorBuilder Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.17.5 VectorBuilder Recent Developments

11.18 GenScript ProBio

11.18.1 GenScript ProBio Corporation Information

11.18.2 GenScript ProBio Business Overview

11.18.3 GenScript ProBio Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.18.4 GenScript ProBio Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.18.5 GenScript ProBio Recent Developments

11.19 PackGene Biotech

11.19.1 PackGene Biotech Corporation Information

11.19.2 PackGene Biotech Business Overview

11.19.3 PackGene Biotech Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.19.4 PackGene Biotech Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.19.5 PackGene Biotech Recent Developments

11.20 OBiO Technology

11.20.1 OBiO Technology Corporation Information

11.20.2 OBiO Technology Business Overview

11.20.3 OBiO Technology Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.20.4 OBiO Technology Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.20.5 OBiO Technology Recent Developments

11.21 Porton Advanced

11.21.1 Porton Advanced Corporation Information

11.21.2 Porton Advanced Business Overview

11.21.3 Porton Advanced Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.21.4 Porton Advanced Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.21.5 Porton Advanced Recent Developments

11.22 HanBio

11.22.1 HanBio Corporation Information

11.22.2 HanBio Business Overview

11.22.3 HanBio Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes

11.22.4 HanBio Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)

11.22.5 HanBio Recent Developments

12 Adeno-Associated Virus (AAV) Packaging Service Value Chain and Ecosystem Analysis

12.1 Adeno-Associated Virus (AAV) Packaging Service Value Chain (Ecosystem Structure)

12.2 Upstream Analysis

12.2.1 Key Technologies, Platforms and Infrastructure

12.3 Midstream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Adeno-Associated Virus (AAV) Packaging Service Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Adeno-Associated Virus (AAV) Packaging Service Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)

Table 2. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Service Scope, 2021 vs 2025 vs 2032 (US$ Million)

Table 3. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Production Platform, 2021 vs 2025 vs 2032 (US$ Million)

Table 4. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)

Table 5. Global Adeno-Associated Virus (AAV) Packaging Service Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 6. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Region (US$ Million), 2021-2026

Table 7. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Region (US$ Million), 2027-2032

Table 8. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)

Table 9. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Players (US$ Million), 2021-2026

Table 10. Global Adeno-Associated Virus (AAV) Packaging Service Revenue-Based Market Share by Players (2021-2026)

Table 11. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)

Table 12. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Adeno-Associated Virus (AAV) Packaging Service Revenue, 2025

Table 13. Global Adeno-Associated Virus (AAV) Packaging Service Average Gross Margin (%) by Player (2021 vs 2025)

Table 14. Global Adeno-Associated Virus (AAV) Packaging Service Companies Headquarters

Table 15. Global Adeno-Associated Virus (AAV) Packaging Service Market Concentration Ratio (CR5)

Table 16. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis

Table 17. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 18. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Type (US$ Million), 2021-2026

Table 19. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Type (US$ Million), 2027-2032

Table 20. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Service Scope (US$ Million), 2021-2026

Table 21. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Service Scope (US$ Million), 2027-2032

Table 22. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Production Platform (US$ Million), 2021-2026

Table 23. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Production Platform (US$ Million), 2027-2032

Table 24. Key Product Attributes and Differentiation

Table 25. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Application (US$ Million), 2021-2026

Table 26. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Application (US$ Million), 2027-2032

Table 27. Adeno-Associated Virus (AAV) Packaging Service High-Growth Sectors Demand CAGR (2026-2032)

Table 28. Top Customers by Region

Table 29. Top Customers by Application

Table 30. North America Adeno-Associated Virus (AAV) Packaging Service Growth Accelerators and Market Barriers

Table 31. North America Adeno-Associated Virus (AAV) Packaging Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)

Table 32. Europe Adeno-Associated Virus (AAV) Packaging Service Growth Accelerators and Market Barriers

Table 33. Europe Adeno-Associated Virus (AAV) Packaging Service Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 34. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Growth Accelerators and Market Barriers

Table 35. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Central and South America Adeno-Associated Virus (AAV) Packaging Service Investment Opportunities and Key Challenges

Table 37. Central and South America Adeno-Associated Virus (AAV) Packaging Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)

Table 38. Middle East and Africa Adeno-Associated Virus (AAV) Packaging Service Investment Opportunities and Key Challenges

Table 39. Middle East and Africa Adeno-Associated Virus (AAV) Packaging Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)

Table 40. Thermo Fisher Scientific Corporation Information

Table 41. Thermo Fisher Scientific Description and Major Businesses

Table 42. Thermo Fisher Scientific Product Features and Attributes

Table 43. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2021-2026)

Table 44. Thermo Fisher Scientific Revenue Proportion by Product in 2025

Table 45. Thermo Fisher Scientific Revenue Proportion by Application in 2025

Table 46. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2025

Table 47. Thermo Fisher Scientific Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis

Table 48. Thermo Fisher Scientific Recent Developments

Table 49. Lonza Corporation Information

Table 50. Lonza Description and Major Businesses

Table 51. Lonza Product Features and Attributes

Table 52. Lonza Revenue (US$ Million) and Gross Margin (2021-2026)

Table 53. Lonza Revenue Proportion by Product in 2025

Table 54. Lonza Revenue Proportion by Application in 2025

Table 55. Lonza Revenue Proportion by Geographic Area in 2025

Table 56. Lonza Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis

Table 57. Lonza Recent Developments

Table 58. Charles River Laboratories Corporation Information

Table 59. Charles River Laboratories Description and Major Businesses

Table 60. Charles River Laboratories Product Features and Attributes

Table 61. Charles River Laboratories Revenue (US$ Million) and Gross Margin (2021-2026)

Table 62. Charles River Laboratories Revenue Proportion by Product in 2025

Table 63. Charles River Laboratories Revenue Proportion by Application in 2025

Table 64. Charles River Laboratories Revenue Proportion by Geographic Area in 2025

Table 65. Charles River Laboratories Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis

Table 66. Charles River Laboratories Recent Developments

Table 67. Catalent Corporation Information

Table 68. Catalent Description and Major Businesses

Table 69. Catalent Product Features and Attributes

Table 70. Catalent Revenue (US$ Million) and Gross Margin (2021-2026)

Table 71. Catalent Revenue Proportion by Product in 2025

Table 72. Catalent Revenue Proportion by Application in 2025

Table 73. Catalent Revenue Proportion by Geographic Area in 2025

Table 74. Catalent Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis

Table 75. Catalent Recent Developments

Table 76. AGC Biologics Corporation Information

Table 77. AGC Biologics Description and Major Businesses

Table 78. AGC Biologics Product Features and Attributes

Table 79. AGC Biologics Revenue (US$ Million) and Gross Margin (2021-2026)

Table 80. AGC Biologics Revenue Proportion by Product in 2025

Table 81. AGC Biologics Revenue Proportion by Application in 2025

Table 82. AGC Biologics Revenue Proportion by Geographic Area in 2025

Table 83. AGC Biologics Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis

Table 84. AGC Biologics Recent Developments

Table 85. SK pharmteco Corporation Information

Table 86. SK pharmteco Description and Major Businesses

Table 87. SK pharmteco Product Features and Attributes

Table 88. SK pharmteco Revenue (US$ Million) and Gross Margin (2021-2026)

Table 89. SK pharmteco Recent Developments

Table 90. OXB Corporation Information

Table 91. OXB Description and Major Businesses

Table 92. OXB Product Features and Attributes

Table 93. OXB Revenue (US$ Million) and Gross Margin (2021-2026)

Table 94. OXB Recent Developments

Table 95. Forge Biologics Corporation Information

Table 96. Forge Biologics Description and Major Businesses

Table 97. Forge Biologics Product Features and Attributes

Table 98. Forge Biologics Revenue (US$ Million) and Gross Margin (2021-2026)

Table 99. Forge Biologics Recent Developments

Table 100. Viralgen Corporation Information

Table 101. Viralgen Description and Major Businesses

Table 102. Viralgen Product Features and Attributes

Table 103. Viralgen Revenue (US$ Million) and Gross Margin (2021-2026)

Table 104. Viralgen Recent Developments

Table 105. Andelyn Biosciences Corporation Information

Table 106. Andelyn Biosciences Description and Major Businesses

Table 107. Andelyn Biosciences Product Features and Attributes

Table 108. Andelyn Biosciences Revenue (US$ Million) and Gross Margin (2021-2026)

Table 109. Andelyn Biosciences Recent Developments

Table 110. Revvity Corporation Information

Table 111. Revvity Description and Major Businesses

Table 112. Revvity Product Features and Attributes

Table 113. Revvity Revenue (US$ Million) and Gross Margin (2021-2026)

Table 114. Revvity Recent Developments

Table 115. Virovek Corporation Information

Table 116. Virovek Description and Major Businesses

Table 117. Virovek Product Features and Attributes

Table 118. Virovek Revenue (US$ Million) and Gross Margin (2021-2026)

Table 119. Virovek Recent Developments

Table 120. Fortis Life Sciences Corporation Information

Table 121. Fortis Life Sciences Description and Major Businesses

Table 122. Fortis Life Sciences Product Features and Attributes

Table 123. Fortis Life Sciences Revenue (US$ Million) and Gross Margin (2021-2026)

Table 124. Fortis Life Sciences Recent Developments

Table 125. SignaGen Laboratories Corporation Information

Table 126. SignaGen Laboratories Description and Major Businesses

Table 127. SignaGen Laboratories Product Features and Attributes

Table 128. SignaGen Laboratories Revenue (US$ Million) and Gross Margin (2021-2026)

Table 129. SignaGen Laboratories Recent Developments

Table 130. Applied Biological Materials Corporation Information

Table 131. Applied Biological Materials Description and Major Businesses

Table 132. Applied Biological Materials Product Features and Attributes

Table 133. Applied Biological Materials Revenue (US$ Million) and Gross Margin (2021-2026)

Table 134. Applied Biological Materials Recent Developments

Table 135. Takara Bio Corporation Information

Table 136. Takara Bio Description and Major Businesses

Table 137. Takara Bio Product Features and Attributes

Table 138. Takara Bio Revenue (US$ Million) and Gross Margin (2021-2026)

Table 139. Takara Bio Recent Developments

Table 140. VectorBuilder Corporation Information

Table 141. VectorBuilder Description and Major Businesses

Table 142. VectorBuilder Product Features and Attributes

Table 143. VectorBuilder Revenue (US$ Million) and Gross Margin (2021-2026)

Table 144. VectorBuilder Recent Developments

Table 145. GenScript ProBio Corporation Information

Table 146. GenScript ProBio Description and Major Businesses

Table 147. GenScript ProBio Product Features and Attributes

Table 148. GenScript ProBio Revenue (US$ Million) and Gross Margin (2021-2026)

Table 149. GenScript ProBio Recent Developments

Table 150. PackGene Biotech Corporation Information

Table 151. PackGene Biotech Description and Major Businesses

Table 152. PackGene Biotech Product Features and Attributes

Table 153. PackGene Biotech Revenue (US$ Million) and Gross Margin (2021-2026)

Table 154. PackGene Biotech Recent Developments

Table 155. OBiO Technology Corporation Information

Table 156. OBiO Technology Description and Major Businesses

Table 157. OBiO Technology Product Features and Attributes

Table 158. OBiO Technology Revenue (US$ Million) and Gross Margin (2021-2026)

Table 159. OBiO Technology Recent Developments

Table 160. Porton Advanced Corporation Information

Table 161. Porton Advanced Description and Major Businesses

Table 162. Porton Advanced Product Features and Attributes

Table 163. Porton Advanced Revenue (US$ Million) and Gross Margin (2021-2026)

Table 164. Porton Advanced Recent Developments

Table 165. HanBio Corporation Information

Table 166. HanBio Description and Major Businesses

Table 167. HanBio Product Features and Attributes

Table 168. HanBio Revenue (US$ Million) and Gross Margin (2021-2026)

Table 169. HanBio Recent Developments

Table 170. Technologies, Platforms and Infrastructure

Table 171. Distributors List

Table 172. Market Trends and Market Evolution

Table 173. Market Drivers and Opportunities

Table 174. Market Challenges, Risks, and Restraints

Table 175. Research Programs/Design for This Report

Table 176. Key Data Information from Secondary Sources

Table 177. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)

Figure 2. Research Grade Product Picture

Figure 3. Preclinical Grade Product Picture

Figure 4. GMP Grade Product Picture

Figure 5. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Service Scope, 2021 vs 2025 vs 2032 (US$ Million)

Figure 6. Packaging Only Product Picture

Figure 7. Vector Construction and Packaging Product Picture

Figure 8. End-to-End Development and Manufacturing Product Picture

Figure 9. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Production Platform, 2021 vs 2025 vs 2032 (US$ Million)

Figure 10. Adherent HEK293 Product Picture

Figure 11. Suspension HEK293 Product Picture

Figure 12. Baculovirus-Sf9 Product Picture

Figure 13. Other Product Picture

Figure 14. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)

Figure 15. Academic and Research Institutions

Figure 16. Biotechnology Companies

Figure 17. Other

Figure 18. Adeno-Associated Virus (AAV) Packaging Service Report Years Considered

Figure 19. Global Adeno-Associated Virus (AAV) Packaging Service Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 20. Global Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 21. Global Adeno-Associated Virus (AAV) Packaging Service Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)

Figure 22. Global Adeno-Associated Virus (AAV) Packaging Service Revenue-Based Market Share by Region (2021-2032)

Figure 23. Global Adeno-Associated Virus (AAV) Packaging Service Revenue-Based Market Share Ranking (2025)

Figure 24. Tier Distribution by Revenue Contribution (2021 vs 2025)

Figure 25. Research Grade Revenue-Based Market Share by Player in 2025

Figure 26. Preclinical Grade Revenue-Based Market Share by Player in 2025

Figure 27. GMP Grade Revenue-Based Market Share by Player in 2025

Figure 28. Global Adeno-Associated Virus (AAV) Packaging Service Revenue-Based Market Share by Type (2021-2032)

Figure 29. Global Adeno-Associated Virus (AAV) Packaging Service Revenue-Based Market Share by Service Scope (2021-2032)

Figure 30. Global Adeno-Associated Virus (AAV) Packaging Service Revenue-Based Market Share by Production Platform (2021-2032)

Figure 31. Global Adeno-Associated Virus (AAV) Packaging Service Revenue-Based Market Share by Application (2021-2032)

Figure 32. North America Adeno-Associated Virus (AAV) Packaging Service Revenue YoY (US$ Million), 2021-2032

Figure 33. North America Top 5 Players Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) in 2025

Figure 34. North America Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) by Application (2021-2032)

Figure 35. US Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 36. Canada Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 37. Mexico Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 38. Europe Adeno-Associated Virus (AAV) Packaging Service Revenue YoY (US$ Million), 2021-2032

Figure 39. Europe Top 5 Players Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) in 2025

Figure 40. Europe Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) by Application (2021-2032)

Figure 41. Germany Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 42. France Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 43. U.K. Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 44. Italy Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 45. Russia Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 46. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Revenue YoY (US$ Million), 2021-2032

Figure 47. Asia-Pacific Top 8 Players Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) in 2025

Figure 48. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) by Application (2021-2032)

Figure 49. Indonesia Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 50. Japan Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 51. South Korea Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 52. Australia Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 53. India Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 54. Indonesia Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 55. Vietnam Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 56. Malaysia Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 57. Philippines Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 58. Singapore Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 59. Central and South America Adeno-Associated Virus (AAV) Packaging Service Revenue YoY (US$ Million), 2021-2032

Figure 60. Central and South America Top 5 Players Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) in 2025

Figure 61. Central and South America Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) by Application (2021-2032)

Figure 62. Brazil Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 63. Argentina Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 64. Middle East and Africa Adeno-Associated Virus (AAV) Packaging Service Revenue YoY (US$ Million), 2021-2032

Figure 65. Middle East and Africa Top 5 Players Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) in 2025

Figure 66. Middle East and Africa Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) by Application (2021-2032)

Figure 67. GCC Countries Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 68. Israel Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 69. Egypt Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 70. South Africa Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million), 2021-2032

Figure 71. Adeno-Associated Virus (AAV) Packaging Service Value Chain Mapping

Figure 72. Channels of Distribution (Direct Vs Distribution)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Adeno-Associated Virus (AAV) Packaging Service in 2026? zhanKai

The global market size of Adeno-Associated Virus (AAV) Packaging Service in 2026 was 1397 Million USD.

What is the annual compound growth rate of the global Adeno-Associated Virus (AAV) Packaging Service market size from 2026 to 2032? shouQi

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Adeno-Associated Virus (AAV) Packaging Service market? shouQi

What was the global market size of Adeno-Associated Virus (AAV) Packaging Service in 2032? shouQi

Related Reports

Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Adeno-Associated Virus (AAV) Packaging Service market size was US$ 1249 million in 2025 and is forecast to reach a readjusted size of US$ 2627 million by 2032 with a CAGR of 11.1% during the forecast period 2026-2032.
Published Date: 2026-07-18
Pages: 149
USD 4250.00
(Single User License)
Adeno-Associated Virus (AAV) Packaging Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1249 million in 2025 and is projected to reach US$ 2627 million, growing at a CAGR of 11.1% from 2026 to 2032.
Published Date: 2026-07-18
Pages: 153
USD 3950.00
(Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Research Report 2026
The global Adeno-Associated Virus (AAV) Packaging Service market was valued at US$ 1249 million in 2025 and is anticipated to reach US$ 2627 million by 2032, at a CAGR of 11.1% from 2026 to 2032.
Published Date: 2026-07-18
Pages: 144
USD 2900.00
(Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Adeno-Associated Virus (AAV) Packaging Service market size was US$ 1390 million in 2024 and is forecast to a readjusted size of US$ 2488 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 107
USD 4250.00
(Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Adeno-Associated Virus (AAV) Packaging Service market is projected to grow from US$ 1390 million in 2024 to US$ 2488 million by 2031, at a CAGR of 8.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 147
USD 4900.00
(Single User License)
Adeno-Associated Virus (AAV) Packaging Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1390 million in 2024 and is forecast to a readjusted size of US$ 2488 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 122
USD 3950.00
(Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Research Report 2025
The global market for Adeno-Associated Virus (AAV) Packaging Service was valued at US$ 1390 million in the year 2024 and is projected to reach a revised size of US$ 2488 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Published Date: 2025-03-12
Pages: 98
USD 2900.00
(Single User License)
Global and United States Adeno-Associated Virus (AAV) Packaging Service Market Report & Forecast 2024-2030
The global Adeno-Associated Virus (AAV) Packaging Service revenue was US$ 1282 million in 2023 and is forecast to a readjusted size of US$ 2305 million by 2030 with a CAGR of 8.8% during the review period (2024-2030).
Published Date: 2025-01-01
Pages: 125
USD 4350.00
(Single User License)
Adeno-Associated Virus (AAV) Packaging Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1282 million in 2023 and is forecast to a readjusted size of US$ 2305 million by 2030 with a CAGR of 8.8% during the forecast period 2024-2030.
Published Date: 2025-01-01
Pages: 125
USD 3950.00
(Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Insights, Forecast to 2030
Valued at US$ 1390 million in 2024, the global Adeno-Associated Virus (AAV) Packaging Service market is forecast to reach US$ 2305 million by 2030, at a CAGR of 8.8% during the forecast period.
Published Date: 2025-01-01
Pages: 159
USD 4900.00
(Single User License)

Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Adeno-Associated Virus (AAV) Packaging Service market size was US$ 1249 million in 2025 and is forecast to reach a readjusted size of US$ 2627 million by 2032 with a CAGR of 11.1% during the forecast period 2026-2032.
Published: 2026-07-18
Pages: 149
USD 4250.00 (Single User License)
Adeno-Associated Virus (AAV) Packaging Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1249 million in 2025 and is projected to reach US$ 2627 million, growing at a CAGR of 11.1% from 2026 to 2032.
Published: 2026-07-18
Pages: 153
USD 3950.00 (Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Research Report 2026
The global Adeno-Associated Virus (AAV) Packaging Service market was valued at US$ 1249 million in 2025 and is anticipated to reach US$ 2627 million by 2032, at a CAGR of 11.1% from 2026 to 2032.
Published: 2026-07-18
Pages: 144
USD 2900.00 (Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Adeno-Associated Virus (AAV) Packaging Service market size was US$ 1390 million in 2024 and is forecast to a readjusted size of US$ 2488 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 107
USD 4250.00 (Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Adeno-Associated Virus (AAV) Packaging Service market is projected to grow from US$ 1390 million in 2024 to US$ 2488 million by 2031, at a CAGR of 8.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 147
USD 4900.00 (Single User License)
Adeno-Associated Virus (AAV) Packaging Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1390 million in 2024 and is forecast to a readjusted size of US$ 2488 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 122
USD 3950.00 (Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Research Report 2025
The global market for Adeno-Associated Virus (AAV) Packaging Service was valued at US$ 1390 million in the year 2024 and is projected to reach a revised size of US$ 2488 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Published: 2025-03-12
Pages: 98
USD 2900.00 (Single User License)
Global and United States Adeno-Associated Virus (AAV) Packaging Service Market Report & Forecast 2024-2030
The global Adeno-Associated Virus (AAV) Packaging Service revenue was US$ 1282 million in 2023 and is forecast to a readjusted size of US$ 2305 million by 2030 with a CAGR of 8.8% during the review period (2024-2030).
Published: 2025-01-01
Pages: 125
USD 4350.00 (Single User License)
Adeno-Associated Virus (AAV) Packaging Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1282 million in 2023 and is forecast to a readjusted size of US$ 2305 million by 2030 with a CAGR of 8.8% during the forecast period 2024-2030.
Published: 2025-01-01
Pages: 125
USD 3950.00 (Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Insights, Forecast to 2030
Valued at US$ 1390 million in 2024, the global Adeno-Associated Virus (AAV) Packaging Service market is forecast to reach US$ 2305 million by 2030, at a CAGR of 8.8% during the forecast period.
Published: 2025-01-01
Pages: 159
USD 4900.00 (Single User License)